Manipulation of fatty acid amide hydrolase functional activity alters sensitivity and dependence to ethanol

Journal of Neurochemistry

Volumn 104, Issue 1, 2008, Pages 233-243

  Vinod, K Yaragudri ^a,b   Sanguino, Elena ^c   Yalamanchili, Ratnakumar ^b   Manzanares, Jorge ^c   Hungund, Basalingappa L ^a,b,d  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^d Columbia University ^*  (United States)

Author keywords

Cannabinoid 1 receptor; Ethanol; Fatty acid amide hydrolase; G protein; Opioid; Preference

Indexed keywords

ALCOHOL; AMIDE; CANNABINOID 1 RECEPTOR; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; FATTY ACID AMIDASE; GUANINE NUCLEOTIDE BINDING PROTEIN; MU OPIATE RECEPTOR; N ARACHIDONOYL ETHANOLAMIDE; PROENKEPHALIN; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CAUDATE NUCLEUS; COMPARATIVE STUDY; CONTROLLED STUDY; CONVULSION; CORPUS STRIATUM; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENE DELETION; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; REINFORCEMENT; SEDATION;

ALCOHOL DRINKING; AMIDOHYDROLASES; ANALGESICS; ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; BENZAMIDES; BENZOXAZINES; CARBAMATES; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CHOICE BEHAVIOR; DRUG INTERACTIONS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALINS; ETHANOL; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HYPOTHERMIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHOLINES; MOTOR ACTIVITY; NAPHTHALENES; PROTEIN BINDING; PROTEIN PRECURSORS; RECEPTOR, CANNABINOID, CB1;

MUS;

EID: 37249036062     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04956.x     Document Type: Article

References (58)

1. Basavarajappa B. S., Yalamanchili R., Cravatt B. F., Cooper T. B. Hungund B. L. (2006) Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice. Neuropharmacology 50, 834 844.
2. Blednov Y. A., Walker D., Alva H., Creech K., Findlay G. Harris R. A. (2003) GABAA receptor alpha 1 and beta 2 subunit null mutant mice: behavioral responses to ethanol. J. Pharmacol. Exp. Ther. 305, 854 863.
3. Blednov Y. A., Cravatt B. F., Boehm S. L. II., Walker D. Harris R. A. (2007) Role of endocannabinoids in alcohol consumption and intoxication: studies of mice lacking fatty acid amide hydrolase. Neuropsychopharmacology 32, 1570 1582.
4. Chen F. Lawrence A. J. (2000) Effect of chronic ethanol and withdrawal on the mu-opioid receptor- and 5-Hydroxytryptamine(1A) receptor-stimulated binding of [(35)S]Guanosine-5′-O-(3-thio)triphosphate in the fawn-hooded rat brain: a quantitative autoradiography study. J. Pharmacol. Exp. Ther. 293, 159 165.
5. Chester J. A., Blose A. M. Froehlich J. C. (2003) Further evidence of an inverse genetic relationship between innate differences in alcohol preference and alcohol withdrawal magnitude in multiple selectively bred rat lines. Alcohol. Clin. Exp. Res. 27, 377 387.
6. Chiang K. P., Gerber A. L., Sipe J. C. Cravatt B. F. (2004) Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. Hum. Mol. Genet. 13, 2113 2119.
7. Childers S. R. Breivogel C. S. (1998) The functional neuroanatomy of brain cannabinoid receptors. Neurobiol. Dis. 5, 417 431.
8. Choi D. S., Cascini M. G., Mailliard W., Young H., Paredes P., McMahon T., Diamond I., Bonci A. Messing R. O. (2004) The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat. Neurosci. 7, 855 861.
9. Colombo G., Agabio R., Fa M., Guano L., Lobina C., Loche A., Reali R. Gessa G. L. (1998) Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the CB antagonist SR-141716. Alcohol Alcohol 33, 126 130.
10. Colombo G., Serra S., Brunetti G., Gomez R., Melis S., Vacca G., Carai M. M. Gessa L. (2002) Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology 159, 181 187.
11. Corchero J., Romero J., Berrendero F., Fernandez-Ruiz J., Ramos J. A., Fuentes J. A. Manzanares J. (1999) Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen. Brain Res. Mol. Brain Res. 67, 148 157.
12. Cravatt B. F., Demarest K., Patricelli M. P., Bracey M. H., Giang D. K., Martin B. R. Lichtman A. H. (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl Acad. Sci. USA 98, 9371 9376.
13. De Witte P., Pinto E., Ansseau M. Verbanck P. (2003) Alcohol and withdrawal: from animal research to clinical issues. Neurosci. Biobehav. Rev. 27, 189 197.
14. Deutsch D. G., Glaser S. T., Howell J. M., Kunz J. S., Puffenbarger R. A., Hillard C. J. Abumrad N. (2001) The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase. J. Biol. Chem. 276, 6967 6973.
15. Devane W. A., Hanus L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G., Gibson D., Mandelbaum A., Etinger A. Mechoulam R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946 1949.
16. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J. C. Piomelli D. (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372, 686 691.
17. Faingold C. L., N'Gouemo P. Riaz A. (1998) Ethanol and neurotransmitter interactions - from molecular to integrative effects. Prog. Neurobiol. 55, 509 535.
18. Gallate J. E., Mallet P. E. McGregor I. S. (2004) Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats. Psychopharmacology 173, 210 216.
19. Gonzalez S., Fernandez-Ruiz J., Sparpaglione V., Parolaro D. Ramos J. A. (2002a) Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB1 receptor binding and mRNA levels. Drug Alcohol Depend. 66, 77 84.
20. Gonzalez S., Cascio M. G., Fernandez-Ruiz J., Fezza F., Di Marzo V. Ramos J. A. (2002b) Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res. 954, 73 81.
21. Hampson A. J., Bornheim L. M., Scanziani M., Yost C. S., Gray A. T., Hansen B. M., Leonoudakis D. J. Bickler P. E. (1998) Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. J. Neurochem. 70, 671 676.
22. Hansson A. C., Bermudez-Silva F. J., Malinen H., Hyytia P., Sanchez-Vera I., Rimondini R., Rodriguez de Fonseca F., Kunos G., Sommer W. H. Heilig M. (2007) Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference. Neuropsychopharmacology 32, 117 126.
23. Hayase T., Yamamoto Y. Yamamoto K. (2001) Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms. J. Pharm. Pharmacol. 53, 1525 1532.
24. Houchi H., Babovic D., Pierrefiche O., Ledent C., Daoust M. Naassila M. (2005) CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors. Neuropsychopharmacology 30, 339 349.
25. Howlett A. C. (2005) Cannabinoid receptor signaling. Handbook Exp. Pharmacol. 168, 53 79.
26. Hungund B. L., Szakall I., Adam A., Basavarajappa B. S. Vadasz C. (2003) Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary EtOH consumption and lack ethanol-induced dopamine release in the nucleus accumbens. J. Neurochem. 84, 698 704.
27. Job M. O., Tang A., Hall F. S., Sora I., Uhl G. R., Bergeson S. E. Gonzales R. A. (2007) Mu (mu) opioid receptor regulation of ethanol-induced dopamine response in the ventral striatum: evidence of genotype specific sexual dimorphic epistasis. Biol. Psychiatry 62, 627 634.
28. Jones S. Bonci A. (2005) Synaptic plasticity and drug addiction. Curr. Opin. Pharmacol. 5, 20 25.
29. Kliethermes C. L., Cronise K. Crabbe J. C. (2004) Anxiety-like behavior in mice in two apparatuses during withdrawal from chronic ethanol vapor inhalation. Alcohol. Clin. Exp. Res. 28, 1012 1019.
30. Maneuf Y. P., Nash J. E., Crossman A. R. Brotchie J. M. (1996) Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus. Eur. J. Pharmacol. 308, 161 164.
31. Manzanares J., Ortiz S., Oliva J. M., Perez-Rial S. Palomo T. (2005) Interactions between cannabinoid and opioid receptor systems in the mediation of ethanol effects. Alcohol Alcohol 40, 25 34.
32. Misra K. Pandey S. C. (2003) Differences in basal levels of CREB and NPY in nucleus accumbens regions between C57BL/6 and DBA/2 mice differing in inborn alcohol drinking behavior. J. Neurosci. Res. 74, 967 975.
33. Misra K. Pandey S. C. (2006) The decreased cyclic-AMP dependent-protein kinase A function in the nucleus accumbens: a role in alcohol drinking but not in anxiety-like behaviors in rats. Neuropsychopharmacology 31, 1406 1419.
34. Naassila M., Pierrefiche O., Ledent C. Daoust M. (2004) Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice. Neuropharmacology 46, 243 253.
35. Nowak K. L., Vinod K. Y. Hungund B. L. (2006) Pharmacological manipulation of CB1 receptor function alters development of tolerance to alcohol. Alcohol Alcohol 41, 24 32.
36. Ortiz S., Oliva J. M., Perez-Rial S., Palomo T. Manzanares J. (2004) Chronic ethanol consumption regulates cannabinoid CB1 receptor gene expression in selected regions of rat brain. Alcohol Alcohol 39, 88 92.
37. Paxinos G. Franklin K. B. J. (2001) The Mouse Brain in Stereotaxic Coordinates. Academic Press, New York.
38. Pugh G. Jr., Smith P. B., Dombrowski D. S. Welch S. P. (1996) The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord. J. Pharmacol. Exp. Ther. 279, 608 616.
39. Ripley T. L., Dunworth S. J. Stephens D. N. (2002) Effect of CGP39551 administration on the kindling of ethanol-withdrawal seizures. Psychopharmacology 163, 157 165.
40. Romero J., de Miguel R., Ramos J. A. Fernandez-Ruiz J. J. (1998) The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake. Life Sci. 62, 351 363.
41. Saland L. C., Hastings C. M., Abeyta A. Chavez J. B. (2005) Chronic ethanol modulates delta and mu-opioid receptor expression in rat CNS: immunohistochemical analysis with quantitiative confocal microscopy. Neurosci. Lett. 381, 163 168.
42. Schlicker E. Kathmann M. (2001) Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci. 22, 565 572.
43. Schmidt L. G., Samochowiec J., Finckh U., Fiszer-Piosik E., Horodnicki J., Wendel B., Rommelspacher H. Hoehe M. R. (2002) Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. Drug Alcohol Depend. 65, 221 224.
44. 35S]GTPγS autoradiography in rat brain. J. Neurosci. 16, 8057 8066.
45. Sim-Selley L. J., Sharpe A. L., Vogt L. J., Brunk L. K., Selley D. E. Samson H. H. (2002) Effect of ethanol self-administration on mu- and delta-opioid receptor-mediated G-protein activity. Alcohol. Clin. Exp. Res. 26, 688 694.
46. Sipe J. C., Chiang K., Gerber A. L., Beutler E. Cravatt B. F. (2002) A missense mutation in human fatty acid amide hydrolase associated with problem drug use. Proc. Natl Acad. Sci. USA 99, 8394 8399.
47. Solbrig M. V., Adrian R., Beretta J., Piomelli D. Giuffrida A. (2005) A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena. Exp. Neurol. 194, 355 362.
48. Solinas M., Justinova Z., Goldberg S. R. Tanda G. (2006) Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats. J. Neurochem. 98, 408 419.
49. Tanda G., Pontieri F. E. Di Chiara G. (1997) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276, 2048 2050.
50. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol. Pharmacol. 47, 848 854.
51. Valverde O., Noble F., Beslot F., Dauge V., Fournie-Zaluski M. C. Roques B. P. (2001) Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect. Eur. J. Neurosci. 13, 1816 1824.
52. Vinod K. Y. Hungund B. L. (2006) Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders. Expert Opin. Ther. Targets 10, 203 210.
53. Vinod K. Y., Yalamanchilli R., Xie S., Cooper R. Hungund B. L. (2006) Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system. Neurochem. Int. 49, 619 625.
54. Wallace M. J., Martin B. R. DeLorenzo R. J. (2002) Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur. J. Pharmacol. 452, 295 301.
55. Wang L., Harvey-White J., Zimmer A. Kunos G. (2003) Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc. Natl Acad. Sci. USA 100, 1393 1398.
56. Welch S. P. Eads M. (1999) Synergistic interactions of endogenous opioids and cannabinoid systems. Brain Res. 848, 183 190.
57. Yao L., McFarland K., Fan P., Jiang Z., Ueda T. Diamond I. (2006) Adenosine A2a blockade prevents synergy between mu-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats. Proc. Natl Acad. Sci. USA 103, 7877 7882.
58. Zimmer A., Zimmer A. M., Hohmann A. G., Herkenham M. Bonner T. I. (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl Acad. Sci. USA 96, 5780 5785.